MAA, an S&P 500 company, is a real estate investment trust (REIT) focused on delivering full-cycle and superior investment performance for shareholders through the ownership, management, acquisition, development and redevelopment of quality apartment communities primarily in the Southeast, Southwest and Mid-Atlantic regions of the United States. As of September 30, 2024, MAA had ownership interest in 104,469 apartment units, including communities currently in development, across 16 states and the District of Columbia.

Mid-America Apartment Communities Inc.

An announcement from Drugs Made In America Acquisition Corp. ( ($DMAA) ) is now available. On April 7, 2026, Drugs Made in America Acquisition Corp...

Drugs Made in America SPAC Signs Power Analytics LOI

In a report released on April 1, Torsten Sauter from Kepler Capital maintained a Hold rating on Komax Holding AG, with a price target of CHF80.00. ...

Kepler Capital  Remains a Hold on Komax Holding AG (KOMN)

Kepler Capital analyst Christophe dombu maintained a Buy rating on MaaT Pharma on March 31 and set a price target of €17.00. The company’s shares c...

Kepler Capital  Sticks to Its Buy Rating for MaaT Pharma (MAAT)

Drugs Made In America Acquisition Corp. ( ($DMAA) ) has released a notification of late filing. Drugs Made in America Acquisition Corp. has filed a...

Drugs Made in America Delays Annual Filing

BMO Capital analyst John Kim maintained a Buy rating on Mid-America Apartment yesterday and set a price target of $155.00. Kim covers the Real Esta...

Mid-America Apartment (MAA) Gets a Buy from BMO Capital

An update from Drugs Made In America Acquisition Corp. ( ($DMAA) ) is now available. On March 23, 2026, Drugs Made In America Acquisition Corp. iss...

Drugs Made In America Signs Financing and Sponsor Deal

In a report released on March 10, Torsten Sauter from Kepler Capital maintained a Hold rating on Komax Holding AG, with a price target of CHF80.00....

Current Quarter	$2.13	Next Quarter	$2.1
Current Year	$8.56	Next Year	$8.73
QoQ Growth	-1.4%	YoY Growth	+2.0%
3Y EPS CAGR	-0.9%	Target Price	$143.81
Consensus	Buy	Upside	+14.4%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MAA	$125.75	+1.17%	428.36K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MAA	$125.75	+1.2%	428.36K
3
4
5
6

MAA

MAA

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Mid-America Apartment Communities Inc. Data in Excel

Get Mid-America Apartment Communities Inc. Data in Excel